Corrigendum: Incidence and Prognostic Significance of PD-L1 Expression in High-Grade Salivary Gland Carcinoma.

Fang, Qigen; Wu, Yao; Du, Wei; Zhang, Xu; Chen, Defeng

Fang, Qigen; Wu, Yao; Du, Wei; Zhang, Xu; Chen, Defeng.

Afiliação

Fang Q; Department of Head Neck and Thyroid, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
Wu Y; Department of Head Neck and Thyroid, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
Du W; Department of Head Neck and Thyroid, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
Zhang X; Department of Head Neck and Thyroid, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
Chen D; Department of Head Neck and Thyroid, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.

Front Oncol ; 11: 836903, 2021.

Article em En | MEDLINE | ID: mdl-35036356

Palavras-chave

PD-L1; high-grade salivary gland carcinoma; immunotherapy; salivary gland carcinoma; survival

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Incidence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google